Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25–26 in non-small cell lung carcinomas

This publication has 12 references indexed in Scilit:

• Molecular basis of the VHL hereditary cancer syndrome
  Nature Reviews Cancer, 2002
• TheVon Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas
  International Journal of Cancer, 2000
• Mapping of chromosome 3p deletions in human epithelial ovarian tumors
  Oncogene, 1998
• Frequent Loss of Heterozygosity on Chromosomes 3p and 17p without VHL or p53 Mutations Suggests Involvement of Unidentified Tumor Suppressor Genes in Follicular Thyroid Carcinoma
  Journal of Clinical Endocrinology & Metabolism, 1997
• Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues
  Human Pathology, 1997
• Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
  Proceedings of the National Academy of Sciences, 1996
• MUTATION OF THEVHL GENE IS ASSOCIATED EXCLUSIVELY WITH THE DEVELOPMENT OF NON-PAPILLARY RENAL CELL CARCINOMAS
  The Journal of Pathology, 1996
• Tumour suppression by the human von Hippel-Lindau gene product
  Nature Medicine, 1995
• Allelic Loss at Chromosomes 3p, 8p, 13q, and l7p Associated With Poor Prognosis in Head and Neck Cancer
  JNCI Journal of the National Cancer Institute, 1994
• Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
  Science, 1993